Joseph Hull
Director/Board Member chez PALATIN TECHNOLOGIES, INC.
Fortune : 37 909 $ au 31/03/2024
Profil
Joseph Stanley Hull is an Independent Director at Palatin Technologies, Inc. since 2005.
He was previously a Senior Vice President-Pharmaceuticals at GlaxoSmithKline LLC from 1987 to 2010.
Before that, he was a VP & Director-Therapeutic Development at Glaxo Wellcome, Inc. Mr. Hull completed his undergraduate degree at The University of North Carolina at Greensboro.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/09/2023 | 20 272 ( 0,13% ) | 37 909 $ | 31/03/2024 |
Postes actifs de Joseph Hull
| Sociétés | Poste | Début |
|---|---|---|
| PALATIN TECHNOLOGIES, INC. | Director/Board Member | 15/09/2005 |
Anciens postes connus de Joseph Hull
| Sociétés | Poste | Fin |
|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/05/2010 |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Formation de Joseph Hull
| The University of North Carolina at Greensboro | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Glaxo Wellcome, Inc. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
